{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:38:39Z","timestamp":1791855519264,"version":"4.3.4"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1001\/jamadermatol.2018.0465","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T12:38:26Z","timestamp":1527079106000},"page":"761","source":"Crossref","is-referenced-by-count":11,"title":["Topical Sirolimus to Treat Tuberous Sclerosis Complex (TSC)"],"prefix":"10.1001","volume":"154","author":[{"given":"Thomas N.","family":"Darling","sequence":"first","affiliation":[{"name":"Department of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"ded180005r1","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1001\/jamadermatol.2014.938","article-title":"Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements.","volume":"150","author":"Teng","year":"2014","journal-title":"JAMA Dermatol"},{"key":"ded180005r2","article-title":"Efficacy and safety of topical rapamycin in patients with facial angiofibromas secondary to tuberous sclerosis complex: the TREATMENT randomized clinical trial","author":"Koenig","journal-title":"JAMA Dermatol"},{"issue":"5","key":"ded180005r3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/exd.2007.16.issue-5","article-title":"Calcineurin inhibitors and rapamycin: cancer protection or promotion?","volume":"16","author":"Weischer","year":"2007","journal-title":"Exp Dermatol"},{"issue":"5","key":"ded180005r4","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1067\/mjd.2001.117525","article-title":"Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.","volume":"45","author":"Bornh\u00f6vd","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"ded180005r5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.pediatrneurol.2016.07.003","article-title":"Applying the lessons of tuberous sclerosis: the 2015 Hower Award Lecture.","volume":"63","author":"Roach","year":"2016","journal-title":"Pediatr Neurol"},{"issue":"1","key":"ded180005r6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13023-017-0596-2","article-title":"mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders.","volume":"12","author":"Franz","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"ded180005r7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/archdermatol.2010.125","article-title":"Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis.","volume":"146","author":"Haemel","year":"2010","journal-title":"Arch Dermatol"},{"key":"ded180005r8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2016.04.003","article-title":"Topical use of mammalian target of rapamycin (mTOR) inhibitors in tuberous sclerosis complex: a comprehensive review of the literature.","volume":"61","author":"J\u00f3zwiak","year":"2016","journal-title":"Pediatr Neurol"},{"issue":"1","key":"ded180005r9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jamadermatol.2016.3545","article-title":"Efficacy and safety of topical sirolimus therapy for facial angiofibromas in the tuberous sclerosis complex: a randomized clinical trial.","volume":"153","author":"Wataya-Kaneda","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"5","key":"ded180005r10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jaad.2015.07.018","article-title":"Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus.","volume":"73","author":"Nathan","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"ded180005r11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jaad.2017.04.005","article-title":"Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: a prospective study of 25 patients.","volume":"77","author":"Malissen","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"ded180005r12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1158\/1940-6207.CAPR-15-0419","article-title":"Inhibition of Akt enhances the chemopreventive effects of topical rapamycin in mouse skin.","volume":"9","author":"Dickinson","year":"2016","journal-title":"Cancer Prev Res (Phila)"},{"issue":"8","key":"ded180005r13","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/hmg\/ddt597","article-title":"Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex.","volume":"23","author":"Tyburczy","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"7","key":"ded180005r14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jamadermatol.2014.4298","article-title":"Clinical and histologic analysis of the efficacy of topical rapamycin therapy against hypomelanotic macules in tuberous sclerosis complex.","volume":"151","author":"Wataya-Kaneda","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"1","key":"ded180005r15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1001\/jamadermatol.2016.3697","article-title":"Efficacy of topical sirolimus (rapamycin) for the treatment of microcystic lymphatic malformations.","volume":"153","author":"Ivars","year":"2017","journal-title":"JAMA Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2682031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T18:45:06Z","timestamp":1531334706000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.0465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.0465","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,1]]}}}